Loading...
Market
Story
Biden Proposes Medicare, Medicaid Cover Obesity Drugs Like Wegovy for Over 7 Million Americans
Nov 26, 2024, 02:41 PM
The Biden administration has proposed expanding Medicare and Medicaid coverage to include anti-obesity medications, such as Wegovy, Ozempic, and Zepbound. This initiative aims to recognize obesity as a treatable disease and would potentially make these medications accessible to 3.4 million Americans with Medicare and 4 million Americans with Medicaid who are living with obesity. The proposed expansion could reduce out-of-pocket expenses for some individuals by up to 95% and is estimated to cost taxpayers approximately $35 billion over the next nine years. The plan has garnered support from bipartisan members of Congress, including Representatives Gwen Moore and Raul Ruiz, and is seen as a significant step toward addressing obesity as a public health issue. Following the announcement, shares of weight-loss drug makers Novo Nordisk and Eli Lilly rose.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Approved as proposed • 25%
Approved with modifications • 25%
Rejected • 25%
No decision by deadline • 25%
Yes • 50%
No • 50%
